Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05991687 · ClinicalTrials.gov registry record · NA

Methods for Effective Disposal of Surplus Analgesics to Facilitate Elimination

A NA study of Surgery and Analgesics, Opioids, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05991687 is a NA study of Surgery and Analgesics, Opioids that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 100 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05991687, a NA study of Surgery and Analgesics, Opioids, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to evaluate the difference in outcomes for mail-in vs. in-home disposal methods for leftover prescription opioids after discharge from surgery.

Interventions

  • OTHER In-home drug disposal pouch
  • OTHER Mail-in prepaid envelope

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-07-31
Est. Completion 2026-08
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05991687

The ClinicalTrials.gov registry entry for NCT05991687 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which In-home drug disposal pouch is the first listed.

NCT05991687 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05991687 about?

NCT05991687 is a clinical study titled "Methods for Effective Disposal of Surplus Analgesics to Facilitate Elimination". The primary objective is to evaluate the difference in outcomes for mail-in vs. in-home disposal methods for leftover prescription opioids after discharge from surgery.

What is the current status of trial NCT05991687?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-07-31. Estimated completion is 2026-08.

What conditions does trial NCT05991687 study?

This clinical trial studies the following conditions: Surgery, Analgesics, Opioids.

What interventions are being tested in trial NCT05991687?

The interventions under investigation include: In-home drug disposal pouch (OTHER), Mail-in prepaid envelope (OTHER).

Who is sponsoring clinical trial NCT05991687?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05991687 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.